English - NObreath

Jan 13

coVita™ and Allergy Partners team up to improve asthma care in America

Innovative NObreath® FeNO device is the allergists' device of choice in the USA. coVita™ LLC, a leader in advanced breath analysis and diagnostic solutions, serves as the U.S. distributor for the innovative NObreath® Fractional Exhaled Nitric Oxide (FeNO) device from UK-based Bedfont® Scientific Ltd. The new agreement with Allergy Partners... read more →

Jan 06

Bedfont® Scientific Limited is proud to exhibit cutting-edge breath analysis devices at WHX Dubai.

Smokerlyzer®, Gastrolyzer®, and NObreath® devices on show at the world’s largest healthcare event. Bedfont® Scientific, world leaders in breath analysis, with over 49 years of experience in the medical breath analysis industry, is thrilled to be showing its innovative devices at this year’s World Health Expo (WHX) Dubai, from the... read more →

Nov 27

Bedfont® Scientific Limited Expands Global Access to FeNO Testing in India

Rbeck Healthtech Private completes registration for the NObreath® FeNO device, helping to improve asthma care across the region. Bedfont® Scientific Limited, world leaders in breath analysis, with over 48 years of experience in designing and manufacturing medical breath analysis devices, has collaborated with Rbeck Healtech Private to make Fractional exhaled... read more →

Nov 27

Practical insights for asthma care: The new NICE/BTS/SIGN guidelines. Why FeNO first?

Part 3: Asthma treatment in 2024: Navigating the new recommendations for every age After exploring diagnostic changes and the pivotal role of Fractional exhaled Nitric Oxide (FeNO) in asthma care, part 3 of our series shifts the focus to treatment and long-term management. From the latest recommendations for patients aged... read more →

Nov 20

Practical insights for asthma care: The new NICE/BTS/SIGN guidelines. Why FeNO first?

Part 2: Why FeNO first? Spotlight on testing & special cases In Part 1, we explored the redefined approach to asthma diagnosis under the new NICE/BTS/SIGN guidelines. In Part 2, we dive deeper into the role of Fractional exhaled Nitric Oxide (FeNO) testing, looking at why it is now a... read more →

Nov 13

Practical insights for asthma care: The new NICE/BTS/SIGN guidelines. Why FeNO first?

Part 1: Understanding the changes – Asthma diagnosis & first steps in the new guidelines In light of the recent update to the National Institute of Care Excellence (NICE) guidelines for asthma care and management, Bedfont® Scientific Limited sponsored an informative webinar by Intermedical (UK) Limited. Seasoned respiratory nurse Carol... read more →

Nov 06

Bedfont® Scientific Limited and Aerosol Medical Systems partner, expanding access to FeNO testing in Latin America

The NObreath® device enhances access to FeNO diagnostics in Mexico. Bedfont® Scientific Limited, a world leader in breath analysis with nearly 50 years of expertise in the medical breath analysis industry, has formed a strategic partnership with Aerosol Medical Systems to improve Fractional exhaled Nitric Oxide (FeNO) testing accessibility in Latin... read more →

Oct 31

Winter is coming: preparing asthma patients with FeNO monitoring

Research has shown that seven out of ten people with asthma report that cold air exacerbates their asthma symptoms1. As winter approaches quickly, it is essential to prepare for asthma management in advance. A vital tool in asthma management, as recommended by the National Institute for Health and Care Excellence... read more →

Aug 18

Back to School: Managing Childhood Asthma

September sees the return to school for children after the summer holidays. While the return to routine is welcomed, it can be challenging for children with asthma. Research by Asthma + Lung UK found that in 2022/2023, there was a 348% rise in hospital admissions in 5-14-year-olds with an asthma... read more →

May 28

Clinical guidelines on FeNO

Fractional exhaled Nitric Oxide (FeNO) is extensively utilised in both primary and secondary care settings worldwide. Many regions recommend FeNO-guided management as part of their clinical protocols. This article reviews FeNO-related guidelines in the UK and internationally, with a focus on comparing approaches across different regions. Guidelines NICE, BTS, and... read more →